Dr. Hyunseok Kim, MD, MPH

Dr. Kim practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Kim's NPI, 1558758524, was assigned on April 17, 2015. Dr. Kim graduated from Yonsei University College of Medicine in 2012. Dr. Kim's California license number on file is A186926.

Dr. Kim's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Kim's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Kim is also affiliated with CHA Hollywood Presbyterian Medical Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Kim to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kim is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Kim's licenses on file in 4 states: California, Massachusetts, Texas and New Jersey.

Dmand AI lists cirrhosis of the liver and upper GI endoscopy among the conditions Dr. Kim treats.

CMS data shows 290 Medicare services from Dr. Kim across 6 procedure codes in 2024, for 186 Medicare patients. Medicare paid $29,295 for them.

CMS counts 186 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 64, with 51% women.

In 2024, Dr. Kim wrote 358 Medicare Part D claims for 132 patients. 74% of them were for generic drugs. CMS names the drug for 187 of them, across 10 drugs with 11 or more claims each, at $113,357 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kim for performance year 2024, reported as part of a group. Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Kim, published from 2017 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Carcinoma, Hepatocellular, Hepatitis B virus and Liver Neoplasms. Dr. Kim's most frequent co-authors are Ju Dong Yang, MD, Amit Singal, MD and Vatche Garen Agopian, MD.

CMS Open Payments shows 34 general payments to Dr. Kim from 10 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $856.

Dr. Kim graduated from Yonsei University College of Medicine in 2012.

Dr. Kim is in network with 17 carriers, including Aetna, Elevance and Highmark. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.